Oncology

The CGTLive™ Oncology specialty topic page highlights the latest clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various cancers. It also houses video interviews with key opinion leaders in the field of oncology speaking to the related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for oncologic diseases.

Latest News

Around the Helix: Cell and Gene Therapy Company Updates – June 18, 2025
Around the Helix: Cell and Gene Therapy Company Updates – June 18, 2025

June 18th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Eugenio Galli, MD, PhD, on Reexamining Frailty as a Barrier to CAR-T Treatment
Eugenio Galli, MD, PhD, on Reexamining Frailty as a Barrier to CAR-T Treatment

June 16th 2025

Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital
The Safety Profile of J&J's CD19/CD20-Targeted CAR-T Therapy JNJ-90014496 in R/R LBCL

June 15th 2025

Omotayo Fasan, MRCP, DTM&H, MBBS, the head of the clinical development program at Galapagos
Omotayo Fasan, MRCP, DTM&H, MBBS, on Evaluating CAR-T GLPG5101 in R/R NHL

June 15th 2025

Saurabh Dahiya, MD, FACP, an associate professor of medicine at Stanford University School of Medicine and the clinical director of cancer cell therapy in the Division of Blood and Marrow Transplantation and Cell Therapy at Stanford Medicine
CAR-T KITE-363's Safety Profile in R/R B-Cell Lymphoma

June 14th 2025

Latest CME Events & Activities

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

View More

Go To PER in Chicago

May 30, 2025 - June 3, 2025

Register Now!

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

View More

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

View More

More News

FDA Activity Recap: April 2025 Features Major Approval in RDEB, Multiple Breakthrough Therapy Designations, and More

FDA Activity Recap: April 2025 Features Major Approval in RDEB, Multiple Breakthrough Therapy Designations, and More

Noah Stansfield
May 1st 2025

Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.

Around the Helix: Cell and Gene Therapy Company Updates – April 30, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 30, 2025

Noah Stansfield
April 30th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – April 25, 2025

Noah Stansfield
April 25th 2025

Review top news and interview highlights from the week ending April 25, 2025.

BrainChild Bio's Pediatric Brain Tumor CAR-T BCB-276 Reels in Breakthrough Therapy Designation

BrainChild Bio's Pediatric Brain Tumor CAR-T BCB-276 Reels in Breakthrough Therapy Designation

Noah Stansfield
April 25th 2025

The FDA’s decision was supported by data indicating overall survival benefit for patients with brain tumors from the phase 1 BrainChild-03 clinical trial.

Around the Helix: Cell and Gene Therapy Company Updates – April 23, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 23, 2025

Noah Stansfield
April 23rd 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center

Supporting Translational Cell Therapy Research

Renier Brentjens, MD, PhD;Noah Stansfield
April 21st 2025

Renier Brentjens, MD, PhD, the chair of the department of medicine at Roswell Park Comprehensive Cancer Center, discussed the need to bring more innovations from nonclinical research to patients.

Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center

Barriers to Accessibility for CAR-T

Renier Brentjens, MD, PhD;Noah Stansfield
April 20th 2025

Renier Brentjens, MD, PhD, the chair of the department of medicine at Roswell Park Comprehensive Cancer Center, discussed his views on toxicities and costs associated with CAR-T, and when and how the field should address them.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – April 18, 2025

Noah Stansfield
April 18th 2025

Review top news and interview highlights from the week ending April 18, 2025.

Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center

Autologous Versus Allogeneic CAR-T for the Near-Term Future

Renier Brentjens, MD, PhD;Noah Stansfield
April 17th 2025

Renier Brentjens, MD, PhD, the chair of the department of medicine at Roswell Park Comprehensive Cancer Center, discussed his view on how the cell therapy field should proceed with regard to innovation.

Around the Helix: Cell and Gene Therapy Company Updates – April 16, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 16, 2025

Noah Stansfield
April 16th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center

Using Armored CAR T-Cells to Tackle Solid Tumors

Renier Brentjens, MD, PhD;Noah Stansfield
April 14th 2025

Renier Brentjens, MD, PhD, the chair of the department of medicine at Roswell Park Comprehensive Cancer Center, discussed the innovations necessary to make CAR-T therapy effective in solid tumor indications.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – April 11, 2025

Noah Stansfield
April 11th 2025

Review top news and interview highlights from the week ending April 11, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – April 9, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 9, 2025

Noah Stansfield
April 9th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center

Renier Brentjens, MD, PhD, on Barriers to Accessibility for CAR-T

Renier Brentjens, MD, PhD;Noah Stansfield
April 9th 2025

The chair of the department of medicine at Roswell Park Comprehensive Cancer Center discussed his views on toxicities and costs associated with CAR-T, and when and how the field should address them.

Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center

Renier Brentjens, MD, PhD, on Autologous Versus Allogeneic CAR-T for the Near-Term Future

Renier Brentjens, MD, PhD;Noah Stansfield
April 8th 2025

The chair of the department of medicine at Roswell Park Comprehensive Cancer Center discussed his view on how the cell therapy field should proceed with regard to innovation.

Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center

Renier Brentjens, MD, PhD, on Using Armored CAR T-Cells to Tackle Solid Tumors

Renier Brentjens, MD, PhD;Noah Stansfield
April 7th 2025

The chair of the department of medicine at Roswell Park Comprehensive Cancer Center discussed the innovations necessary to make CAR-T therapy effective in solid tumor indications.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – April 4, 2025

Noah Stansfield
April 4th 2025

Review top news and interview highlights from the week ending April 4, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025

Noah Stansfield
April 2nd 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Data Roundup: March 2025 Features Updates from MDA's Conference, an Alzheimer Disease Trial, and More

Data Roundup: March 2025 Features Updates from MDA's Conference, an Alzheimer Disease Trial, and More

Noah Stansfield
April 1st 2025

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – March 28, 2025

Noah Stansfield
March 28th 2025

Review top news and interview highlights from the week ending March 28, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – March 26, 2025

Around the Helix: Cell and Gene Therapy Company Updates – March 26, 2025

Noah Stansfield
March 26th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

National Colorectal Cancer Awareness Month 2025: Looking Back at Progress for Cell Therapy

National Colorectal Cancer Awareness Month 2025: Looking Back at Progress for Cell Therapy

Noah Stansfield
March 24th 2025

In observance of National Colorectal Cancer Awareness Month, held annually in March, we took a look back at news in cell therapy for colorectal cancer indications.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – March 21, 2025

CGTLive Staff
March 21st 2025

Review top news and interview highlights from the week ending March 21, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – March 19, 2025

Around the Helix: Cell and Gene Therapy Company Updates – March 19, 2025

Noah Stansfield
March 19th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Shanxi Bethune Hospital Evaluating CAR-T for R/R Hematological Tumors in Phase 2/3 Clinical Trial

Shanxi Bethune Hospital Evaluating CAR-T for R/R Hematological Tumors in Phase 2/3 Clinical Trial

Noah Stansfield
March 17th 2025

CGTLive® took a closer look at the single-center, open-label study, which aims to assess the safety and efficacy of the CAR-T therapy.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – March 14, 2025

CGTLive Staff
March 14th 2025

Review top news and interview highlights from the week ending March 14, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – March 12, 2025

Around the Helix: Cell and Gene Therapy Company Updates – March 12, 2025

Noah Stansfield
March 12th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – March 7, 2025

CGTLive Staff
March 7th 2025

Review top news and interview highlights from the week ending March 7, 2025.

Data Roundup: February 2025 Features Updates from WORLDSymposium, Tandem Meetings, and More

Data Roundup: February 2025 Features Updates from WORLDSymposium, Tandem Meetings, and More

CGTLive Staff
March 6th 2025

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

Around the Helix: Cell and Gene Therapy Company Updates – March 5, 2025

Around the Helix: Cell and Gene Therapy Company Updates – March 5, 2025

Noah Stansfield
March 5th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

<12345678
...
70>
© 2025 MJH Life Sciences

All rights reserved.